Sodium zirconium cyclosilicate for hyperkalemia: a collateral acid-base benefit?
Nephrol Dial Transplant
.
2021 Apr 26;36(5):756-760.
doi: 10.1093/ndt/gfaa241.
Author
Donald E Wesson
1
Affiliation
1
Department of Internal Medicine, Texas A&M College of Medicine, Dallas, TX, USA.
PMID:
33179742
DOI:
10.1093/ndt/gfaa241
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Hyperkalemia* / drug therapy
Potassium
Silicates
Substances
Silicates
sodium zirconium cyclosilicate
Potassium